SOLID TUMOR PANEL TESTING

Savannah Life Sciences provides panel testing that cover the key genes associated with targeted therapies, aimed at a successful treatment of the several types of cancer. In these panels, next-generation sequencing (NGS) is used which allows greater coverage of analysis for each gene region, requiring minimal amounts of tumor materials/samples, without any interference with the effects caused by the storage of the paraffin-embedded (FFPE) samples.